CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 185 enrolled
Drug / intervention
PRO-SELF PLUS Pain Management Programbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00708019
NCT00708019N/ACompleted

Improving Cancer Pain Management Through Self-Care

University of California, San Francisco·interventional·Posted Jul 2, 2008·Updated May 5, 2016

In Brief

A clinical study evaluating PRO-SELF PLUS Pain Management Program for Cancer and Pain. Completed, enrolled 185 participants across 2 sites.

Detailed Summary

This study will test two different doses of a psychoeducational intervention to improve cancer pain management. In addition, the study will determine if the changes in pain management behaviors that the patients and family caregivers learn continue to be used when the intervention stops. It is hypothesized that patients and family caregivers who receive the high dose intervention will have a greater decrease in pain intensity scores.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer, Pain
CountriesUnited States

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 2, 2008
Enrollment StartDec 1, 2007
Primary CompletionDec 1, 2012
Study CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 18 years ago

Interventions

PRO-SELF PLUS Pain Management Programbehavioral

The psychoeducational intervention will be conducted by specially trained oncology nurses and will include the components of knowledge, skills training, and coaching to improve cancer pain management. Patients in both groups will be seen in their homes over the course of 10 weeks with phone calls conducted in between the home visits. Patients in the HIGH-DOSE group will receive 6 visits and 10 phone calls \[total time 12.3 hours\]. Patients in the LOW-DOSE group will receive 4 visits and 6 phone calls \[8.0 hours\]. Follow-up visits to assess the sustainability of the intervention will be done at 2 weeks, 1 month and 3 months after the intervention. Both quantitative and qualitative analyses will be conducted to evaluate patient outcomes.